Iron Chelators with Topoisomerase-Inhibitory Activity and Their Anticancer Applications
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Iron Chelators with Topoisomerase-Inhibitory Activity and Their Anticancer Applications
Authors
Keywords
-
Journal
ANTIOXIDANTS & REDOX SIGNALING
Volume 18, Issue 8, Pages 930-955
Publisher
Mary Ann Liebert Inc
Online
2012-08-20
DOI
10.1089/ars.2012.4877
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Silibinin Suppresses Growth of Human Colorectal Carcinoma SW480 Cells in Culture and Xenograft through Down-regulation of β-Catenin-Dependent Signaling
- (2015) Manjinder Kaur et al. NEOPLASIA
- Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
- (2014) Daniel J. Klionsky et al. Autophagy
- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
- (2014) Tomáš Šimůnek et al. Pharmacological Reports
- Synthesis, Characterization and Antiproliferative Activity of 1,2-Naphthoquinone and Its Derivatives
- (2012) S. Shukla et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- The anticancer thiosemicarbazones Dp44mT and triapine lack inhibitory effects as catalytic inhibitors or poisons of DNA topoisomerase IIα
- (2012) Jack C. Yalowich et al. BIOCHEMICAL PHARMACOLOGY
- Oxidative chemistry of fluorescent dyes: implications in the detection of reactive oxygen and nitrogen species
- (2012) Balaraman Kalyanaraman BIOCHEMICAL SOCIETY TRANSACTIONS
- Current and Proposed Biomarkers of Anthracycline Cardiotoxicity in Cancer: Emerging Opportunities in Oxidative Damage and Autophagy
- (2012) J. S. Dickey et al. CURRENT MOLECULAR MEDICINE
- Editorial (Hot Topic: Biomarkers of Oxidative Stress and Cancer: From Chemistry, Biology to Clinical Applications and Personalized Therapy)
- (2012) Alexandros G. Georgakilas et al. CURRENT MOLECULAR MEDICINE
- Dexrazoxane treatment of doxorubicin extravasation injury in four dogs
- (2012) Rachel O. Venable et al. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
- DNA cleavage and opening reactions of human topoisomerase II are regulated via Mg2+-mediated dynamic bending of gate-DNA
- (2012) S. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Escherichia coli topoisomerase I is an iron and zinc binding protein
- (2011) Jianxin Lu et al. BIOMETALS
- Role of hypoxia-inducible factors in the dexrazoxane-mediated protection of cardiomyocytes from doxorubicin-induced toxicity
- (2011) RD Spagnuolo et al. BRITISH JOURNAL OF PHARMACOLOGY
- The iron chelator Dp44mT inhibits the proliferation of cancer cells but fails to protect from doxorubicin-induced cardiotoxicity in spontaneously hypertensive rats
- (2011) V. Ashutosh Rao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- An Iron Regulatory Gene Signature Predicts Outcome in Breast Cancer
- (2011) L. D. Miller et al. CANCER RESEARCH
- Antitumor Activity of Metal-Chelating Compound Dp44mT Is Mediated by Formation of a Redox-Active Copper Complex That Accumulates in Lysosomes
- (2011) D. B. Lovejoy et al. CANCER RESEARCH
- The Medicinal Chemistry of Novel Iron Chelators for the Treatment of Cancer
- (2011) Zaklina Kovacevic et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: Implications for the reactive oxygen species-mediated mechanisms of chemobrain
- (2011) Christopher D. Aluise et al. FREE RADICAL BIOLOGY AND MEDICINE
- Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations
- (2011) Balaraman Kalyanaraman et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cellular Iron Depletion and the Mechanisms Involved in the Iron-dependent Regulation of the Growth Arrest and DNA Damage Family of Genes
- (2011) Federica Saletta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis and characterization of mixed-ligand diimine-piperonal thiosemicarbazone complexes of ruthenium(II): Biophysical investigations and biological evaluation as anticancer and antibacterial agents
- (2011) Floyd A. Beckford et al. JOURNAL OF MOLECULAR STRUCTURE
- Factors Influencing the DNA Nuclease Activity of Iron, Cobalt, Nickel, and Copper Chelates
- (2011) Jeff C. Joyner et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Cell death assays for drug discovery
- (2011) Oliver Kepp et al. NATURE REVIEWS DRUG DISCOVERY
- Tumor Topoisomerase II Alpha Status and Response to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer
- (2011) Alíz Nikolényi et al. ONCOLOGY
- p53 Regulates Oxidative Stress-Mediated Retrograde Signaling: A Novel Mechanism for Chemotherapy-Induced Cardiac Injury
- (2011) Joyce M. Velez et al. PLoS One
- Chelation of Lysosomal Iron Protects Dopaminergic SH-SY5Y Neuroblastoma Cells from Hydrogen Peroxide Toxicity by Precluding Autophagy and Akt Dephosphorylation
- (2011) Roberta Castino et al. TOXICOLOGICAL SCIENCES
- Advances in metal-induced oxidative stress and human disease
- (2011) Klaudia Jomova et al. TOXICOLOGY
- A Historical Perspective of Anthracycline Cardiotoxicity
- (2011) Michael S. Ewer et al. Heart Failure Clinics
- What does the commonly used DCF test for oxidative stress really show?
- (2010) Markus Karlsson et al. BIOCHEMICAL JOURNAL
- Topoisomerase II-α as a predictive factor of response to therapy with anthracyclines in locally advanced breast cancer
- (2010) Henry L. Gómez et al. BREAST
- Anti-tumor and radiosensitization activities of the iron chelator HDp44mT are mediated by effects on intracellular redox status
- (2010) Junqiang Tian et al. CANCER LETTERS
- Cyclophilin A release as a biomarker of necrotic cell death
- (2010) D E Christofferson et al. CELL DEATH AND DIFFERENTIATION
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
- (2010) Yves Pommier et al. CHEMISTRY & BIOLOGY
- Development of a Validated Immunofluorescence Assay for H2AX as a Pharmacodynamic Marker of Topoisomerase I Inhibitor Activity
- (2010) R. J. Kinders et al. CLINICAL CANCER RESEARCH
- Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: Another inconvenient truth
- (2010) Jacek Zielonka et al. FREE RADICAL BIOLOGY AND MEDICINE
- Advances in methods for the determination of biologically relevant lipid peroxidation products
- (2010) Corinne M. Spickett et al. FREE RADICAL RESEARCH
- Cardioprotective effect of dexrazoxane in a rat model of myocardial infarction: Anti-apoptosis and promoting angiogenesis
- (2010) Ligang Zhou et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Antioxidant Transcription Factor Nrf2 Negatively Regulates Autophagy and Growth Arrest Induced by the Anticancer Redox Agent Mitoquinone
- (2010) V. Ashutosh Rao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TDP2/TTRAP Is the Major 5′-Tyrosyl DNA Phosphodiesterase Activity in Vertebrate Cells and Is Critical for Cellular Resistance to Topoisomerase II-induced DNA Damage
- (2010) Zhihong Zeng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional characterization of iron-substituted neural zinc finger factor 1: metal and DNA binding
- (2010) Angelique N. Besold et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Topoisomerase IIα expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer
- (2010) Christian Schindlbeck et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Cardiotoxicity After Childhood Cancer: Beginning With the End in Mind
- (2010) Steven E. Lipshultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer
- (2010) Markhaba Tukenova et al. JOURNAL OF CLINICAL ONCOLOGY
- The iron complex of Dp44mT is redox-active and induces hydroxyl radical formation: An EPR study
- (2010) Patric J. Jansson et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Dexrazoxane for Preventing Anthracycline Cardiotoxicity in Children with Solid Tumors
- (2010) Hyoung Soo Choi et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- A Series of α-Heterocyclic Carboxaldehyde Thiosemicarbazones Inhibit Topoisomerase IIα Catalytic Activity
- (2010) He Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
- (2010) Steven E Lipshultz et al. LANCET ONCOLOGY
- The use of divalent metal ions by type II topoisomerases
- (2010) Joseph E. Deweese et al. Metallomics
- A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases
- (2010) Bryan H. Schmidt et al. NATURE
- Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?
- (2010) Douglas B. Sawyer et al. PROGRESS IN CARDIOVASCULAR DISEASES
- A two-domain structure for the two subunits of NAD(P)H:quinone acceptor oxidoreductase
- (2010) Shiuan Chen et al. PROTEIN SCIENCE
- Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity
- (2010) Z. Kovacevic et al. Current Drug Delivery
- Alterations of cellular organelles in human liver-derived hepatoma G2 cells induced by adriamycin
- (2009) Haoran Qian et al. ANTI-CANCER DRUGS
- Autophagy of HSP70 and chelation of lysosomal iron in a non-redox-active form
- (2009) Tino Kurz et al. Autophagy
- Use of Divalent Metal Ions in the DNA Cleavage Reaction of Human Type II Topoisomerases†
- (2009) Joseph E. Deweese et al. BIOCHEMISTRY
- Metal Ion Interactions in the DNA Cleavage/Ligation Active Site of Human Topoisomerase IIα
- (2009) Joseph E. Deweese et al. BIOCHEMISTRY
- Specific iron chelators determine the route of ferritin degradation
- (2009) I. De Domenico et al. BLOOD
- The Iron Chelator Dp44mT Causes DNA Damage and Selective Inhibition of Topoisomerase II in Breast Cancer Cells
- (2009) V. A. Rao et al. CANCER RESEARCH
- Thiosemicarbazones: the new wave in cancer treatment
- (2009) Danuta S Kalinowski et al. Future Medicinal Chemistry
- Synthetic and natural iron chelators: therapeutic potential and clinical use
- (2009) Heather C Hatcher et al. Future Medicinal Chemistry
- Hydroxyl Radicals Are Involved in Cell Killing by the Bacterial Topoisomerase I Cleavage Complex
- (2009) I-F. Liu et al. JOURNAL OF BACTERIOLOGY
- Transcription Factor GATA4 Inhibits Doxorubicin-induced Autophagy and Cardiomyocyte Death
- (2009) Satoru Kobayashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The iron chelator Dp44mT does not protect myocytes against doxorubicin
- (2009) Brian B. Hasinoff et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Topoisomerase II -dependent and -independent apoptotic effects of dexrazoxane and doxorubicin
- (2009) T. Yan et al. MOLECULAR CANCER THERAPEUTICS
- Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity
- (2009) T. D. Pfister et al. MOLECULAR CANCER THERAPEUTICS
- Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft
- (2009) M. Kaur et al. MOLECULAR CANCER THERAPEUTICS
- A human 5′-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage
- (2009) Felipe Cortes Ledesma et al. NATURE
- Effects of magnesium and related divalent metal ions in topoisomerase structure and function
- (2009) C. Sissi et al. NUCLEIC ACIDS RESEARCH
- High throughput evaluation of gamma-H2AX
- (2009) Dane Avondoglio et al. Radiation Oncology
- Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells
- (2008) Egarit Noulsri et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
- (2008) D.R. Richardson et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model
- (2008) Ping Xiang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- 2,3-Dehydrosilybin Is a Better DNA Topoisomerase I Inhibitor than Its Parental Silybin
- (2008) Piyanut Thongphasuk et al. CHEMOTHERAPY
- Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses
- (2008) Jia-Rong Fan et al. DNA REPAIR
- Dynamic states of the DNA repair enzyme AlkB regulate product release
- (2008) Boris Bleijlevens et al. EMBO REPORTS
- HPLC study of oxidation products of hydroethidine in chemical and biological systems: ramifications in superoxide measurements
- (2008) Jacek Zielonka et al. FREE RADICAL BIOLOGY AND MEDICINE
- Redox Control of the DNA Damage-inducible Protein DinG Helicase Activity via Its Iron-Sulfur Cluster
- (2008) Binbin Ren et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human topoisomerase II uses a two-metal-ion mechanism for DNA cleavage
- (2008) J. E. Deweese et al. NUCLEIC ACIDS RESEARCH
- The MCK mouse heart model of Friedreich's ataxia: Alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation
- (2008) M. Whitnall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Topoisomerase levels determine chemotherapy responsein vitroandin vivo
- (2008) Darren J. Burgess et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytochrome c-mediated oxidation of hydroethidine and mito-hydroethidine in mitochondria: Identification of homo- and heterodimers
- (2007) Jacek Zielonka et al. FREE RADICAL BIOLOGY AND MEDICINE
- Detection of 2-hydroxyethidium in cellular systems: a unique marker product of superoxide and hydroethidine
- (2007) Jacek Zielonka et al. Nature Protocols
- Regulation of iron acquisition and storage: consequences for iron-linked disorders
- (2007) Ivana De Domenico et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started